Yuanhua Intelligent Exhibits HX Orthopedic Surgical Robot at 9th China International Import Expo

Leaderobot.com reported that Yuanhua Intelligent exhibited its in-house-developed HX robotic-arm orthopedic surgical robot at the 9th China International Import Expo. The expo opened on November 5, and this was Yuanhua Intelligent’s fourth consecutive year exhibiting there, the report said.

According to Leaderobot.com, Yuanhua Intelligent says it developed the HX’s robotic arm, navigation system and underlying algorithms in-house, and that 100% of its core components are domestically made. How consistently this applies to the actual product and its maintenance is a point for surgical facilities to consider when evaluating supply and continued operation.

The focus of the exhibit is not only the finished surgical robot, but also the report that Yuanhua Intelligent developed components including the robotic arm, navigation and control algorithms in-house, and that 100% of its core components are domestically made. However, these claims were reported by Leaderobot.com, and exhibiting at a trade fair does not independently verify the component supply chain, manufacturing reproducibility or performance in medical settings. The report gives the navigation system’s update rate as 335 Hz and its positioning error as within 0.1 millimeter, but the article does not specify the evaluation conditions or measurement methods. The figures should not be directly equated with clinical effectiveness and need to be assessed in context. We reported in a Sept. 14 article that Yuanhua Intelligent presented its Kunwu® full orthopedic surgical robot at a conference in Boao, Hainan. Yuanhua Intelligent presents the Kunwu® full orthopedic surgical robot’s capabilities in complex cases in Boao. The focus this time is a different product, the HX, and the Kunwu® presentation cannot be treated as evidence of the HX’s performance or adoption. The two products show that the company has exhibited and presented different surgical robots, but the available information does not establish whether they share components, software or clinical data. From an industry-structure perspective, if the claims of domestically made core components and in-house system development are accurate, they point to a model in which the company manages specification changes across navigation and control as well as robotic-arm manufacturing. But the claim of “100% domestically made” does not identify which components are covered, who manufactures each one or how parts are supplied for maintenance and replacement. Reports have also mentioned clinical applications in multiple regions, but no consistent data on the number of facilities, case volumes or post-adoption operating status for the HX have been provided. Going forward, points to verify include the testing conditions for the 335 Hz and within-0.1-millimeter specifications, their relationship to clinical outcomes, which components are covered by the domestic-production claim, the maintenance system, and operating records at facilities using the HX. A trade-fair exhibition provides an opportunity to present the product, but information on these points is needed to assess the continuity of mass production and clinical reproducibility. See the original report for details.